Overview
AI drug design platform; now part of Recursion.
Details
Exscientia’s Centaur Chemist platform pioneered AI-designed clinical candidates. Merged into Recursion in 2024.
AI drug design platform; now part of Recursion. Exscientia's Centaur Chemist platform pioneered AI-designed clinical candidates. Merged into Recursion in 2024.
AI drug design platform; now part of Recursion.
Exscientia’s Centaur Chemist platform pioneered AI-designed clinical candidates. Merged into Recursion in 2024.